Spotlight interview Geerten P. van Nieuw Amerongen PhD: Showing That Imatinib Protects Against Endothelial Barrier Dysfunction Via Inhibition of the Tyrosine Kinase Abl-Related Gene.

G.P. van Nieuw Amerongen

Research output: Contribution to journalArticleAcademic

Original languageUndefined/Unknown
Pages (from-to)f113-f114
JournalCirculation
Volume127
DOIs
Publication statusPublished - 2013

Cite this